drugset / Trial / NCT07710768
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this clinical study is to find out if UBT251 is safe and effective to be taken together with medicines, like midazolam, caffeine and warfarin in participants living with overweight or obesity.
Timeline
- Start
- 2026-07-15
- Primary completion
- 2027-04-07
- Completion
- 2027-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | UBT251 | Unknown | — | Subcutaneous |
| Subject | Warfarin | Small molecule | — | Oral |